Nitric Oxide and Nitrovasodilators

Total Page:16

File Type:pdf, Size:1020Kb

Nitric Oxide and Nitrovasodilators JACC Vol. 24, No. 2 Aug"I 1994: 55 5-66 555 Nitric Oxide and NitrovasodHators : 541 I'laiities,I Differences and Menfi2l 111teY2CHODS TODD J. ANDERSON, MD,* LAN T . MEREDITH, MD, PuD, PETER GANZ, MD, FACC, ANDREW P. SELWYN, MD, FACC, ALAN C. YEUNG, PAD, FACC Bern.. , Manuchusetts Many similarities exist between the exogenous nitrates and nitric oxide. As such, important interactions might be expected endethelium-derived relaxing factor, which is nitric oalde or a between nitrates and endothelium-dependent processes that in- thiot derivative. Both act by way of guany)nte cyclaw, which volve nitric oxide. TIds review explores the mechanisms of action, increases intracellular concentrations of cyclic guanusine mono- biologic effects and potential interactions between nitrates and endo- phosphate, resulting in smooth muscle cell rdantion and anti- thelium-derives) relaxing factor . platelet effects. Thiols may be important in the (j Am Call Cardiol 1994,24.555-66) of exogenous nitrates and other intracellular pnwesses involving Since the first description of the therapeutic use of glyceryl choline stimulated muscarinic receptors on the endothelium, trinitrate appeared in 1879 (1), organic nitrates have re- leading to the release of a nonprostanoid relaxing factor, mained the cornerstone for the treatment of angina pectoris . which they named endothelium-derived relaxing factor . Over the past decade, emphasis has been placed on research A diffusible substance with a half-life of several seconds, to elucidate the subcellular mechanisms of these com- (6,7) endothelium-derived relaxing factor could be inhibited pounds . During the same period, key discoveries have by hence-containing proteins (8), and it was destroyed by shown that the vascular endothelium plays a pivotal role in oxygen free radicals (10). It also activated soluble guanylate the local control of vasomotor tone, primarily through the cyclase and increased the concentration of cyclic guanosine synthesis and release of endothelium-derived relaxing factor monophosphate (cyclic GIMP) (10). Collectively, these char- (2). 'This substance has now been identified as nitric oxide or acteristics led to the simultaneous observation by Ignarro et a related nitrosothiol whose actions parallel those of organic al . (4) and Furchgott and Khan (5) that endothelium-derived nitiovasodilators (3-5). This review discusses the nature of relaxing factor was strikingly similar to nitric oxide . nitric oxide and the mechanism of action of nitric oxide and The first proof that nitric oxide was at least one of the organic nitrates and explores the interactions that might relaxing factors resulted from studies by Paltrier et al . (11) . exist between them . Using a chemiluminescence assay, they demonstrated that cultured endothelial cells release nitric oxide when exposed Chemical Nature of100hytheliumn-Derived. to bradykinin . In this assay, nitric oxide is specifically Relaxing Factor detected by its reaction with ozone . Results of these studies provided strong evidence that endothelium-derived relaxing In 1980, Furchgott and Zawadzki (2) discovered that the factor is nitric oxide or a chemically related compound . aoety[choline-induced relaxation of rabbit aortic strips re- Recent findings suggest that endothelium-derived relaxing quired an intact endothelium. They concluded that acetyl- factor may also be similar to a labile nitroso compound (S-nitroso-L-cysteine) (3,12) . From the Cardiovascular Division, Brigham and Women's Hospital Boston, Massachusetts . This study was supported by a Clinical Fellowship of Mechanism of Action of Endothelium- The Alberta Heritage Foundation for Medical Research (Dr. Anderson), Alberta, Canada ; a National Heart Foundation of Australia Ralph Reader Derived Relaxing Factor and Overseas Research Fellowship (Dr . Meredith), Melbourne, Australia ; and Organic Nitrates Research Career Development Award I K04 HL02566 (Dr . Ganz), Clinician- Investigatnr Development Award I K08 HL 02787 (Dr . Yeung) and R01 Endothelium-derived relaxing factor . The mechanism of HL-38780-c5 (Dr . Selwyn) from the National Heart, Lung, and Blood insti- action of nitric oxide has been examined in considerable tute, National Institutes of Health, Bethesda, Maryland . Manuscript received September 20, 1993 ; revised manuscript received detail (10,13) . Palmer et al . (14) have demonstrated that January 29, 1994, accepted March 25, 1994. nitric oxide is synthesized from the guanidino nitrogen of the "Present and for comsplindente : Cardiovascular Divi- address address amino acid L-arginine . This conversion is controlled by an sion, Foothills Hospital . 1403 29th Street NW, Calgary, Alberta, Canada T2N-2T9. enzyme, nitric oxide synthase, which can be stimulated by a .00 01994 by the American College of Cardiology 0735-1097/94/$7 JACC Vol . 24, No. 2 556 ANDERSON ET AL. NITRIC OXIDE AND NITRATES August 1594 :555-66 number of physical and chemical stimuli and is inhibited by oxides) (Fig. 2). This distinguishes them from nitric oxide- several arginine analogs, including N °-monomethyl-L- containing compounds without an ester bond, such as nitro- arginine . Receptors on' he endothelial cell membrane mod- prusside. Important similarities and differences exist in the ulate this interaction in association with signal transduction biotransformation of these organic and inorganic nitrates, but it proteins (the G protein family) (15) . Serotonin receptors, for is generally accepted that they share a final cnnunon pathway example, interact with the pertussis-sensitive inhibitory pro- wish endothelium-derived relaxing factor . tein (G;) to modulate release of nitric oxide (16). After The mechanism by which nitroprusside releases nitric release from the endothelium, endothelium-derived relaxing oxide has recently been reported . It has been previously factor diffuses across the extracellular space into the smooth thought that nitric oxide release occurred spontaneously muscle cell and utilizes the guanylate cyclase second- (30). However, more recently Bates et al . (31) have reported messenger system to implement its biologic actions . Both that a one-electron reduction with accompanying cyanide nitric oxide and endothelium-derived relaxing factor have loss was required before nitric oxide could be released . been shown to activate soluble guanylate cyclase, leading to The biotramtsformation of organic nitrates is probably an increase in the intracellular concentration of cyclic GMP more complex . Although there is much controversy about (10,17). the role of thiols, they may be important at several levels in Cycic guanoalne 3'-,5'-momphosphate system: intraccellu- the nitrate/nitric oxide pathway including 1) the formation of lar d r. Cyclic GMP is formed from guanosine S-nitrosothiol intermediaries, and 2) the activation of soluble 5'-triphosphate by the activation of guanylate cyclase, of guanylate cyclase by nitric oxide . The formation of nitro- which there are at least three distinct types: 1) soluble sothiol intermediaries from organic nitrates seems to depend guanylate cyclase, which is activated by nitric oxide and on the denitrification of the R-0-nitric oxide, to a reactive organic nitrates ; 2) membrane-bound (particulate) guanylate thiol intermediary (32,33) . Using a rat model of tolerance, cyclase, which is induced by atrial natriuretic peptide ; and 3) Fung et al. (34) showed that the beneficial effect of the thiol cytoskeleton guanylate cyclase, which is sensitive to E. coil donor N-acetylcysteine on nitroglycerin might be mediated heat-stable enterotoxin (18) . Purified soluble guanylate cy- by extracellular S-nitrosothiol formation in addition to intra- clase has been shown to contain heme, which is now thought cellular thiol repletion . A recent study in rats, which used to be the receptor site for nitric oxide on soluble guanylate various thiol donors and depleting agents, demonstrated that cyclase (19-21) . Electron paramagnetic resonance studies both intracellular and extracellular thiols are important in have demonstrated that the binding of nitric oxide to heme modulating the effect of nitroglycerin in vivo (35) . Although results in a structural change of the hence molecule in which suggestive, it has not been shown conclusively that nitro- the iron atom protrudes out of the plane of the protoporphy- sothiols are intermediaries in the biotransfcrmation process . rin ring (22). Local thiol groups are necessary to reduce the Recent data by Chung and Fang (36) have demonstrated heme iron atom to the ferrous state, thus facilitating the that nitrates are enzymatically converted to yield nitric oxide nitric oxide-heme interaction . by a surface membrane enzyme system that is not identical The net result of the activation of soluble guanylate to that provided by glutathione-S-transferases (37). It has cyclase is the formation of cyclic GMP, which then activates been suggested by these investigators and others (38) that a serinelthreonine protein kinase (cG-Pk) (23) . Several pro- sulfhydryl.donating compounds may act instead as cofactors teins may be phosphorylated by cG-Pk, resulting in smooth in the enzymatic transformation of organic nitrates . muscle relaxation. Cyclic GMP also stimulates calcium Thiols have also been shown to be potentially important efflux and uptake by intracellular stores . It may also inhibit for the antiplatelet effect of the nitrovasodilators . Loscalzo calcium influx across the plasma membrane by decreasing (39) demonstrated that N-acetylcysteine
Recommended publications
  • Chapter 20 *Lecture Powerpoint the Circulatory System: Blood Vessels and Circulation
    Chapter 20 *Lecture PowerPoint The Circulatory System: Blood Vessels and Circulation *See separate FlexArt PowerPoint slides for all figures and tables preinserted into PowerPoint without notes. Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display. Introduction • The route taken by the blood after it leaves the heart was a point of much confusion for many centuries – Chinese emperor Huang Ti (2697–2597 BC) believed that blood flowed in a complete circuit around the body and back to the heart – Roman physician Galen (129–c. 199) thought blood flowed back and forth like air; the liver created blood out of nutrients and organs consumed it – English physician William Harvey (1578–1657) did experimentation on circulation in snakes; birth of experimental physiology – After microscope was invented, blood and capillaries were discovered by van Leeuwenhoek and Malpighi 20-2 General Anatomy of the Blood Vessels • Expected Learning Outcomes – Describe the structure of a blood vessel. – Describe the different types of arteries, capillaries, and veins. – Trace the general route usually taken by the blood from the heart and back again. – Describe some variations on this route. 20-3 General Anatomy of the Blood Vessels Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display. Capillaries Artery: Tunica interna Tunica media Tunica externa Nerve Vein Figure 20.1a (a) 1 mm © The McGraw-Hill Companies, Inc./Dennis Strete, photographer • Arteries carry blood away from heart • Veins
    [Show full text]
  • Response to Inhaled Nitric Oxide, but Neither Sodium Nitroprusside Nor Sildenafil, Predicts Survival in Patients With
    Jachec et al., J Clin Exp Cardiolog 2015, 6:6 Clinical & Experimental Cardiology http://dx.doi.org/10.4172/2155-9880.1000376 Research Article Open Access Response to Inhaled Nitric Oxide, But neither Sodium Nitroprusside nor Sildenafil, Predicts Survival in Patients with Dilated Cardiomyopathy Complicated with Pulmonary Hypertension Wojciech Jacheć1*, Celina Wojciechowska2, Andrzej Tomasik2, Damian Kawecki2, Ewa Nowalany-Kozielska2 and Jan Wodniecki2 1II Katedra i Oddział Kliniczny Kardiologii w Zabrzu Śląskiego Uniwersytetu Medycznego w Katowicach, ul. Skłodowskiej 10, 41-800 Zabrze, Polska 2Department of Cardiology in Zabrze, Medical University of Silesia in Katowice, Poland *Corresponding author: Wojciech Jacheć, II Katedra i Oddział Kliniczny Kardiologii w Zabrzu Śląskiego Uniwersytetu Medycznego w Katowicach, ul. Skłodowskiej 10, 41-800 Zabrze, Polska, Tel: +48 32 373 23 72; Fax: +48 32 271 10 10; E-mail: [email protected] Received date: May 26, 2015, Accepted date: Jun 25, 2015, Published date: Jun 29, 2015 Copyright: ©2015 Jacheć W. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Introduction: Pulmonary hypertension in patients with dilated cardiomyopathy is associated with higher mortality. Objectives: The aim of the study was to assess the predictive value of the vasodilator response to three different drugs, sodium nitroprusside,
    [Show full text]
  • Radionuclear Measurement of Peripheral Hemodynamics In
    RadionuclearMeasurementof Peripheral Hemodynamics in Selection of Vasodilators for Treatment of Heart Failure Yasuhiro Todo, Mitsumasa Ohyanagi, Ryu Fujisue, and Tadaaki Iwasaki Hyogo College ofMedicine, Nishinomiya, Japan Inorder to select the optimal vasodilator for the treatment of patients with congestive heart failure (CHF), the acute effects of three vasodilators (isosorbide dinitrate (ISDN) 5 mg, nifedipine 10 mg, and prazosin 1 mg) on peripheral capacitance and resistance vessels (CV and RV)were evaluated by a newly devised radionuclear technique (Study 1).Thirty-six @ patients with chronic CHF were dividedinto Group A (ejectionfraction (EF) 35%, n = 20, mean EF: 47.2 ±6.5%) and B (EF < 35%, n = 16, mean EF: 24.8 ±7.1%). ISDNproduced the strongest CVdilatation(25% in both groups). Nifedipinereduced RVtone in Groups A and B (14% and 27%, respectively),and CVtone in Group A (6%). Prazosin had the most prominent effects on both vessels in Group B. From these results, it appeared: (a) ISDN is indicated for the cases with increased CV tone, (b) nifedipine is suitable for those with @ increased RV tone, (C)in cases of increased tone in both vessels, nifedipine (when EF 35%) or prazosin (when EF < 35%) is optimal.To evaluate the validityof this assignment, 49 subjects with CHF were divided into Group 1 (n = 16, increased CV tone), Group 2 (n = 17, increased RV tone), and Group 3 (n = 16, increased CV and RV tone) in Study 2. In Group 1, the changes of all indexes were not significantly different between the subjects treated with optimal drug based on the assignment (subgroup P) and those with a non-optimaldrug (subgroup N)after 2 wk of therapy.
    [Show full text]
  • Preparation and Purification of Atmospherically Relevant Α
    Atmos. Chem. Phys., 20, 4241–4254, 2020 https://doi.org/10.5194/acp-20-4241-2020 © Author(s) 2020. This work is distributed under the Creative Commons Attribution 4.0 License. Technical note: Preparation and purification of atmospherically relevant α-hydroxynitrate esters of monoterpenes Elena Ali McKnight, Nicole P. Kretekos, Demi Owusu, and Rebecca Lyn LaLonde Chemistry Department, Reed College, Portland, OR 97202, USA Correspondence: Rebecca Lyn LaLonde ([email protected]) Received: 31 July 2019 – Discussion started: 6 August 2019 Revised: 8 December 2019 – Accepted: 20 January 2020 – Published: 9 April 2020 Abstract. Organic nitrate esters are key products of terpene oxidation in the atmosphere. We report here the preparation and purification of nine nitrate esters derived from (C)-3- carene, limonene, α-pinene, β-pinene and perillic alcohol. The availability of these compounds will enable detailed investigations into the structure–reactivity relationships of aerosol formation and processing and will allow individual investigations into aqueous-phase reactions of organic nitrate esters. Figure 1. Two hydroxynitrate esters with available spectral data. Relative stereochemistry is undefined. 1 Introduction derived ON is difficult, particularly due to partitioning into the aerosol phase in which hydrolysis and other reactivity Biogenic volatile organic compound (BVOC) emissions ac- can occur (Bleier and Elrod, 2013; Rindelaub et al., 2014, count for ∼ 88 % of non-methane VOC emissions. Of the to- 2015; Romonosky et al., 2015; Thomas et al., 2016). Hydrol- tal BVOC estimated by the Model of Emission of Gases and ysis reactions of nitrate esters of isoprene have been stud- Aerosols from Nature version 2.1 (MEGAN2.1), isoprene is ied directly (Jacobs et al., 2014) and the hydrolysis of ON estimated to comprise half, and methanol, ethanol, acetalde- has been studied in bulk (Baker and Easty, 1950).
    [Show full text]
  • Blood Vessels: Part A
    Chapter 19 The Cardiovascular System: Blood Vessels: Part A Blood Vessels • Delivery system of dynamic structures that begins and ends at heart – Arteries: carry blood away from heart; oxygenated except for pulmonary circulation and umbilical vessels of fetus – Capillaries: contact tissue cells; directly serve cellular needs – Veins: carry blood toward heart Structure of Blood Vessel Walls • Lumen – Central blood-containing space • Three wall layers in arteries and veins – Tunica intima, tunica media, and tunica externa • Capillaries – Endothelium with sparse basal lamina Tunics • Tunica intima – Endothelium lines lumen of all vessels • Continuous with endocardium • Slick surface reduces friction – Subendothelial layer in vessels larger than 1 mm; connective tissue basement membrane Tunics • Tunica media – Smooth muscle and sheets of elastin – Sympathetic vasomotor nerve fibers control vasoconstriction and vasodilation of vessels • Influence blood flow and blood pressure Tunics • Tunica externa (tunica adventitia) – Collagen fibers protect and reinforce; anchor to surrounding structures – Contains nerve fibers, lymphatic vessels – Vasa vasorum of larger vessels nourishes external layer Blood Vessels • Vessels vary in length, diameter, wall thickness, tissue makeup • See figure 19.2 for interaction with lymphatic vessels Arterial System: Elastic Arteries • Large thick-walled arteries with elastin in all three tunics • Aorta and its major branches • Large lumen offers low resistance • Inactive in vasoconstriction • Act as pressure reservoirs—expand
    [Show full text]
  • Drug Class Review Antianginal Agents
    Drug Class Review Antianginal Agents 24:12.08 Nitrates and Nitrites 24:04.92 Cardiac Drugs, Miscellaneous Amyl Nitrite Isosorbide Dinitrate (IsoDitrate ER®, others) Isosorbide Mononitrate (Imdur®) Nitroglycerin (Minitran®, Nitrostat®, others) Ranolazine (Ranexa®) Final Report May 2015 Review prepared by: Melissa Archer, PharmD, Clinical Pharmacist Carin Steinvoort, PharmD, Clinical Pharmacist Gary Oderda, PharmD, MPH, Professor University of Utah College of Pharmacy Copyright © 2015 by University of Utah College of Pharmacy Salt Lake City, Utah. All rights reserved. Table of Contents Executive Summary ......................................................................................................................... 3 Introduction .................................................................................................................................... 4 Table 1. Antianginal Therapies .............................................................................................. 4 Table 2. Summary of Agents .................................................................................................. 5 Disease Overview ........................................................................................................................ 8 Table 3. Summary of Current Clinical Practice Guidelines .................................................... 9 Pharmacology ............................................................................................................................... 10 Table 4. Pharmacokinetic Properties
    [Show full text]
  • Acute Effect of Sodium Nitroprusside on Microvascular Dysfunction In
    Clinical Studies Acute Effect of Sodium Nitroprusside on Microvascular Dysfunction in Patients Who Underwent Percutaneous Coronary Intervention for Acute ST-segment Elevation Myocardial Infarction Kotaro Morimoto,1, 2 MD, Shigenori Ito,2 MD, Kosuke Nakasuka,2 MD, Satoru Sekimoto,2 MD, Kazuyuki Miyata,2 MD, Masahiko Inomata,2 MD, Takayuki Yoshida,2 MD, Nozomu Tamai,2 MD, Tomoaki Saeki,2 MD, Shin Suzuki,2 MD, Yoshimasa Murakami,2 MD, Koichi Sato,2 MD, Akihiro Morino,3 CE, and Yoshiyuki Shimizu,3 CE Summary Even in the era of thrombus aspiration and distal protection for ST-segment elevation acute myocardial infarction (STEMI), microvascular dysfunction does exist and improvement of microvascular dysfunction can improve the progno- sis and/or left ventricular dysfunction. We evaluated the acute effects of nitroprusside (NTP) on coronary microvascular injury that occurred after primary percutaneous coronary intervention (PCI) for STEMI in 18 patients. The final Throm- bolysis in Myocardial Infarction trial (TIMI) flow grade after PCI was 3 in 17 patients and 2 in 1 patient. The index of microcirculatory resistance (IMR) was improved significantly from 76 ± 42 to 45 ± 37 (P = 0.0006) by intracoronary NTP administration. IMR improved to the normal range (IMR < 30) in 9 patients (50%). Higher TIMI flow grade and lower IMR at baseline were observed more frequently in patients whose IMR recovered to normal range after NTP ad- ministration. NTP improved the microcirculatory dysfunction at the acute phase in patients who underwent PCI for STEMI and
    [Show full text]
  • Thermal Decomposition of Nitrate Esters1 Michael A. Hiskey, Kay R. Brower, and Jimmie C. Oxley* Department of Chemistry New Mexi
    Thermal Decomposition of Nitrate Esters1 Michael A. Hiskey, Kay R. Brower, and Jimmie C. Oxley* Department of Chemistry New Mexico Institute of Mining and Technology Socorro, New Mexico 87801 Abstract Rates of thermal decomposition and solvent rate effects have been measured for a series of nitrate esters. The alkoxy radicals formed by homolysis together with some of their further degradation products have been stabilized by hydrogen donation. Internal and external return of nitrogen dioxide has been demonstrated by solvent cage effects and isotope exchange. Radical- stabilizing substituents favor β-scission. Dinitrates in a 1,5 relationship behave as isolated mononitrates. Dinitrates in a 1,3 or 1,4 relationship exhibit intramolecular reactions. Tertiary nitrate esters in diethyl ether undergo elimination rather than homolysis. Introduction The esters of nitric acid have long been used as explosives and propellants, and their thermal decomposition products and kinetics have been studied as a means to evaluate the thermal hazards of these compounds. The thermal decomposition of ethanolnitrate was examined by a number of researchers, and it was proposed that the first, and rate-determining, step was the 2-5 reversible loss of NO2: . RCH2O-NO2 <--> RCH2O + NO2 Griffiths, Gilligan, and Gray6 investigated 2-propanol nitrate pyrolysis and found it exhibited more β-cleavage than primary nitrate esters. It yielded nearly equal amounts of 2- propanol nitrite and acetaldehyde, as well as small amounts of acetone, nitromethane, and methyl nitrite (Fig. 1). Homolytic cleavage of the RO-NO2 bond would form the 2-propoxy radical, which could subsequently react with nitric oxide to produce 2-propanol nitrite.
    [Show full text]
  • Soluble Guanylate Cyclase B1-Subunit Expression Is Increased in Mononuclear Cells from Patients with Erectile Dysfunction
    International Journal of Impotence Research (2006) 18, 432–437 & 2006 Nature Publishing Group All rights reserved 0955-9930/06 $30.00 www.nature.com/ijir ORIGINAL ARTICLE Soluble guanylate cyclase b1-subunit expression is increased in mononuclear cells from patients with erectile dysfunction PJ Mateos-Ca´ceres1, J Garcia-Cardoso2, L Lapuente1, JJ Zamorano-Leo´n1, D Sacrista´n1, TP de Prada1, J Calahorra2, C Macaya1, R Vela-Navarrete2 and AJ Lo´pez-Farre´1 1Cardiovascular Research Unit, Cardiovascular Institute, Hospital Clı´nico San Carlos, Madrid, Spain and 2Urology Department, Fundacio´n Jime´nez Diaz, Madrid, Spain The aim was to determine in circulating mononuclear cells from patients with erectile dysfunction (ED), the level of expression of endothelial nitric oxide synthase (eNOS), soluble guanylate cyclase (sGC) b1-subunit and phosphodiesterase type-V (PDE-V). Peripheral mononuclear cells from nine patients with ED of vascular origin and nine patients with ED of neurological origin were obtained. Fourteen age-matched volunteers with normal erectile function were used as control. Reduction in eNOS protein was observed in the mononuclear cells from patients with ED of vascular origin but not in those from neurological origin. Although sGC b1-subunit expression was increased in mononuclear cells from patients with ED, the sGC activity was reduced. However, only the patients with ED of vascular origin showed an increased expression of PDE-V. This work shows for the first time that, independently of the aetiology of ED, the expression of sGC b1-subunit was increased in circulating mononuclear cells; however, the expression of both eNOS and PDE-V was only modified in the circulating mononuclear cells from patients with ED of vascular origin.
    [Show full text]
  • Your Pulse and Target Heart Rate
    Skip to main content ×Close Menu We use cookies to improve your experience on our website. By closing this banner or interacting with our site, you acknowledge and agree to this. Legal Notices MobileClose Menu Find A Doctor Your Visit Pay a Bill Log in to MyGillette Learn more about MyGillette Patient Education Patient Services and Resources Your Rights and Medical Records Understanding Costs, Insurance and the Gillette Assistance Programs Services to Support Your Family Interpreter Services International Patients Parent Resources and Support Prepare for Your Visit Prepare for Clinic Visits and Tests Prepare for Surgery Take a Hospital Tour Transfer Your Medical Records Transportation and Accommodations Ways to Prepare and Comfort Your Child During Your Visit or Hospital Stay Commitment to a Safe and Healing Environment Our Hospital Units Your Hospital Room St. Paul Campus Amenities and Activities Visit or Contact a Patient Conditions & Care All Conditions Cerebral Palsy Neuromuscular Disorders Scoliosis Craniosynostosis Brain Injury All Tests & Treatments Shunt Surgery for Hydrocephalus Gait and Motion Analysis Selective Dorsal Rhizotomy (SDR) Gillette Craniocap© Orthosis Botulinum Toxin and Phenol (Injected Spasticity Medications) All Specialties & Services Orthopedics Rehabilitation Services Craniofacial and Plastic Surgery Neurology Neurosurgery Virtual Visits Pediatric Expert Consults Virtual Rehab Therapy Sleep Medicine Virtual Care Get Involved Advocating for Your Family Community Health United Cerebral Palsy of MN Donors & Supporters
    [Show full text]
  • The Heart Institute
    The Heart Institute Division of Cardiology 4650 Sunset Blvd., #34, Los Angeles, CA 90027 Phone: 323-361-2461 Fax: 323-361-1513 The Heart Institute at Children’s Hospital Los Angeles is CHLA.org/CARDIOLOGY one of the top-ranked pediatric heart programs in the Division of nation—with a long history of exceptional and innovative Cardiothoracic Surgery 4650 Sunset Blvd., #66 care for the most complex pediatric cardiac conditions. Los Angeles, CA 90027 Phone: 323-361-4148 Fax: 323-361-3668 We treat patients from fetus to adulthood and serve as CHLA.org/CTSurgery a major tertiary referral center for all forms of congenital Referrals Phone: 888-631-2452 and acquired heart disease. Fax: 323-361-8988 Email: [email protected] Physician Portal: https://myCHLA.CHLA.org We offer an integrated inpatient and outpatient Our Cardiothoracic Intensive Care Unit (CTICU) complement of services that brings together experts was the first of its kind on the West Coast, using in cardiology, cardiothoracic surgery, cardiothoracic innovative treatments including extracorporeal transplant, cardiothoracic intensive care and membrane oxygenation (ECMO) and ventricular cardiovascular acute care in a centrally located, assist services. state-of-the-art healing environment. With fewer steps to navigate, our patients and families receive care Our two state-of-the-art catheterization laboratories that is more streamlined and less stressful. use the latest technology to provide accurate cardiac data while reducing radiation. Our programmatic emphasis on high-complexity surgeries in neonates has produced outcomes that are among the best in the country, as shown in the most recent Society of Thoracic Surgeons report.
    [Show full text]
  • Relationship Between Vasodilatation and Cerebral Blood Flow Increase in Impaired Hemodynamics: a PET Study with the Acetazolamide Test in Cerebrovascular Disease
    CLINICAL INVESTIGATIONS Relationship Between Vasodilatation and Cerebral Blood Flow Increase in Impaired Hemodynamics: A PET Study with the Acetazolamide Test in Cerebrovascular Disease Hidehiko Okazawa, MD, PhD1,2; Hiroshi Yamauchi, MD, PhD1; Hiroshi Toyoda, MD, PhD1,2; Kanji Sugimoto, MS1; Yasuhisa Fujibayashi, PhD2; and Yoshiharu Yonekura, MD, PhD2 1PET Unit, Research Institute, Shiga Medical Center, Moriyama, Japan; and 2Biomedical Imaging Research Center, Fukui Medical University, Fukui, Japan Key Words: acetazolamide; cerebrovascular disease; cerebral The changes in cerebral blood flow (CBF) and arterial-to- blood volume; vasodilatory capacity; cerebral perfusion pressure capillary blood volume (V0) induced by acetazolamide (ACZ) are expected to be parallel each other in the normal circula- J Nucl Med 2003; 44:1875–1883 tion; however, it has not been proven that the same changes in those parameters are observed in patients with cerebro- vascular disease. To investigate the relationship between changes in CBF, vasodilatory capacity, and other hemody- namic parameters, the ACZ test was performed after an The ability of autoregulation to maintain the cerebral 15O-gas PET study. Methods: Twenty-two patients with uni- blood flow (CBF), which resides in the cerebral circulation lateral major cerebral arterial occlusive disease underwent despite transient changes in systemic mean arterial blood 15 PET scans using the H2 O bolus method with the ACZ test pressure, has been shown to occur via the mechanism of 15 after the O-gas steady-state method. CBF and V0 for each arteriolar vasodilatation in the cerebral circulation (1). The subject were calculated using the 3-weighted integral vasodilatory change in the cerebral arteries is assumed for method as well as the nonlinear least-squares fitting method.
    [Show full text]